Em recrutamento
FASE
Número Europeu 2021-000168-31
M20-621 EPCORE DLBCL-2
A Phase 3, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With R-CHOP Compared to R-CHOP in Subjects With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Detalhes
Destaques